Medication info

PosPhentap Cheopbuje (Pelvinac)

OTC medicationPatch
Ingredient · strength
Felbinac›49mg / 1 sheet
Manufacturer / importer
Daehwa Pharmaceutical Co., Ltd.
Appearance
S-type I: A colorless, transparent, adhesive substance applied to apricot-colored lint cloth, covering the solid surface with a peeling agent. S-type II: A colorless, transparent, adhesive substance applied to red lint cloth, covering the solid surface with a peeling agent.
Packaging
10 sheets/package
Approval status
Active

MFDS item code 200708277 · Notified 2007.07.16

Summary

Main use
Relief of muscle and joint pain, tendinitis and tenosynovitis, and swelling and pain following trauma
Who uses it
Adults
Adult dosage
· S-Type : Remove the release liner from the medicated side and apply 1 patch to the affected area twice daily. · R-Type : Cut to an appropriate length, remove the release liner from the medicated side, and apply to the affected area twice daily.

Ingredients

Manufacturer
Daehwa Pharmaceutical Co., Ltd.

Efficacy & effects

Relief of muscle and joint pain, tendinitis and tenosynovitis, and swelling and pain following trauma

  • Degenerative arthritis
  • adhesive capsulitis
  • tendonitis
  • tenosynovitis
  • lateral epicondylitis
  • muscle pain
  • swelling and pain after trauma.
View approved original text

This medication is effective for inflammatory diseases such as degenerative arthritis, adhesive capsulitis, tendonitis, and tenosynovitis. It is also used to relieve symptoms of lateral epicondylitis (tennis elbow), muscle pain, and swelling and pain after trauma. In other words, it reduces inflammation and pain in joints and muscles, improving discomfort in daily activities. It helps in alleviating pain and inflammation associated with these diseases and symptoms.

Dosage and Administration

Adult dosage

· S-Type : Remove the release liner from the medicated side and apply 1 patch to the affected area twice daily. · R-Type : Cut to an appropriate length, remove the release liner from the medicated side, and apply to the affected area twice daily.

Precautions

This medication should not be used by patients who have had allergic reactions to this medication or its components, or to other Felbinac formulations. Additionally, patients with a history of asthma attacks when using aspirin or other non-steroidal anti-inflammatory drugs should not use this medication, as it may induce asthma attacks. Patients who have experienced hives or acute rhinitis from aspirin or non-steroidal anti-inflammatory drugs should also avoid using this medication. Caution is advised for patients with bronchial asthma, as this medication may trigger asthma attacks. This medication may cause itching, skin redness, erythema, dermatitis, contact dermatitis, and in rare cases, irritation or blisters. If these symptoms worsen, use should be discontinued immediately. Furthermore, rare but severe allergic reactions accompanied by hives or bronchospasm may occur, so caution is necessary. This medication can also cause gastrointestinal disturbances. It is a symptomatic treatment for alleviating inflammation or pain and does not treat the underlying causes, which should be understood. When used in areas with skin infections, it may exacerbate the infection, so it should be used with antibacterial or antifungal agents while monitoring the condition closely. When using for chronic conditions like degenerative arthritis, other treatment options should be considered alongside medication treatment, and the patient's condition and potential side effects should be carefully monitored. In late pregnancy, this medication may cause adverse labor or delayed childbirth, so it should not be used by pregnant women, women who may become pregnant, or nursing mothers. Safety has not been established for children, so it is not recommended for use in pediatric patients. Do not apply to damaged skin, mucous membranes, or areas with eczema or rash, and take care to avoid contact with eyes or mucous membranes. Caution is needed as temporary irritation or tingling may occur when applied to damaged skin. Additionally, this medication should not be used with occlusive dressings.

Side effects

  • Itching
  • erythema
  • redness
  • dermatitis
  • rash
  • eczema
  • contact dermatitis
  • irritation
  • vesicles
  • paresthesia
Show 4 more
  • hives
  • bronchospasm
  • extensive rash
  • gastrointestinal disturbances

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is best to maintain a storage temperature between 1°C and 30°C at room temperature. This will help to maintain the effectiveness of the medication and prevent deterioration.

Appearance and packaging

Appearance

S-type I: A colorless, transparent, adhesive substance applied to apricot-colored lint cloth, covering the solid surface with a peeling agent. S-type II: A colorless, transparent, adhesive substance applied to red lint cloth, covering the solid surface with a peeling agent.

Package unit

10 sheets/package

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.